David M. Jablons

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

November, 2024

David M. Jablons

Jul 24, 2024, 13:40 | Blog

Collin Blakely: Neoadjuvant Osimertinib for the Treatment of Non–Small Cell Lung Cancer

Collin Blakely, Associate Professor of Thoracic Medical Oncology and Clinical Scientist at UCSF, shared a…

Jul 21, 2024, 15:37 | Insight

Neoadjuvant osimertinib for resectable EGFR NSCLC

Stephen V Liu shared on X a recent paper by Collin M. Blakely et al.…

Jul 21, 2024, 13:36 | Blog

Rami Manochakian: Neoadjuvant osimertinib in stage I-IIIA EGFRm NSCLC did not meet primary endpoint

Rami Manochakian shared a post on X: ''Hot off the press. Neoadjuvant Osimertinib for the…

All: 3 Posts: 1 - 100

Dr. Richard Pazdur's 25 Year WAR on Cancer at the FDA!

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023